Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderately to Severely Active Crohns Disease”

Showing 15 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06456593
What this trial is testing

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

Who this might be right for
Moderately to Severely Active Crohn Disease
Abivax S.A. 212
Testing effectiveness (Phase 2)Looking for participantsNCT07483073
What this trial is testing

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

Who this might be right for
Colitis, UlcerativeCrohn Disease
Eli Lilly and Company 60
Large-scale testing (Phase 3)Study completedNCT03782376
What this trial is testing

Evaluate Efficacy and Safety of Ustekinumab Re-induction Therapy in Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn Disease
Janssen-Cilag Ltd. 215
Post-approval studies (Phase 4)Looking for participantsNCT06581328
What this trial is testing

Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

Who this might be right for
Ulcerative ColitisCrohn's Disease
Takeda 200
Not applicableActive Not RecruitingNCT02130362
What this trial is testing

A Non-Interventional Clinical Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients With Moderately to Severely Active Crohn's Disease (CD)

Who this might be right for
Crohn's Disease
AbbVie 1,446
Large-scale testing (Phase 3)Study completedNCT01951326
What this trial is testing

Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease

Who this might be right for
Crohn's Disease
RedHill Biopharma Limited 331
Testing effectiveness (Phase 2)Study completedNCT00630643
What this trial is testing

NI-0401 in Active Crohn's Disease

Who this might be right for
Moderate to Severe Crohn's Disease
Light Chain Bioscience - Novimmune SA 40
Large-scale testing (Phase 3)Looking for participantsNCT06937099
What this trial is testing

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Who this might be right for
Crohn's DiseaseObesity or Overweight
Eli Lilly and Company 290
Testing effectiveness (Phase 2)Ended earlyNCT05688852
What this trial is testing

VTX958 for the Treatment of Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn Disease
Ventyx Biosciences, Inc 107
Large-scale testing (Phase 3)Study completedNCT02914561
What this trial is testing

Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
Lakefront Biotherapeutics NV 1,372
Testing effectiveness (Phase 2)Study completedNCT01714726
What this trial is testing

Evaluation of Efficacy and Safety of MEDI2070 in Patients With Active, Moderate-to-severe Crohn's Disease.

Who this might be right for
Crohn's Disease
AstraZeneca 121
Large-scale testing (Phase 3)Active Not RecruitingNCT06063967
What this trial is testing

Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn's Disease.

Who this might be right for
Crohn's Disease
AbbVie 289
Testing effectiveness (Phase 2)Study completedNCT00265122
What this trial is testing

The Safety and Efficacy of Ustekinumab (CNTO 1275) in Participants With Crohn's Disease

Who this might be right for
Crohn Disease
Centocor, Inc. 131
Testing effectiveness (Phase 2)Study completedNCT00771667
What this trial is testing

Safety and Effectiveness of Ustekinumab in Patients With Moderate to Severe Active Crohn's Disease Who Have Been Previously Treated With Anti-TNF Therapy

Who this might be right for
Crohn's Disease
Centocor, Inc. 526
Large-scale testing (Phase 3)UnknownNCT01817972
What this trial is testing

Cimzia Versus Cimzia Plus Azathioprine in the Treatment of Active Crohn's Disease

Who this might be right for
Crohn's Disease
Gastroenterology Research of America 65

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation